Cytomos (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- June 09, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $5,000,000
Company Info
- Traction
- Cytomos has achieved commercialisation of its first product and has a pipeline of trials planned with global partners, along with strong interest from high-profile technology developers and a top ten pharma company.
- Company Description
- Cytomos is a biotech company that has developed a cell analysis technology platform called AuraCyt, which enhances single-cell analysis and aims to transform biological drug discovery and manufacturing processes.
- Market
- Drug Discovery
- Location
- Edinburgh, Scotland, United Kingdom
- Coinvestors
- Archangels, Old College Capital, Scottish Enterprise, British Business Bank